This meta-analysis showed that people with melanoma who underwent SNB had a significantly reduced risk of death from melanoma and recurrence compared with those who did not. These findings are consistent with the only published randomised controlled trial and were robust on sensitivity analyses, indicating that SNB confers true survival and recurrence benefits.
[Articles] Assessment of survival benefit from sentinel node biopsy for melanoma: a systematic review and meta-analysis
The Lancet Oncology | | Alexander H R Varey, Marie B Weitemeyer, Caroline A Gjorup, Serigne N Lo, Gabrielle J Williams, John F Thompson
Topics: skin-cancer, research